Regeneron CASE: CemiplimAb in Cutaneous Squamous Cell Carcinoma

Sponsor: Regeneron Pharmaceuticals, Inc.

Protocol R2810-ONC-1806. CemiplimAb Survivorship Epidemiology for patients with Cutaneous Squamous Cell Carcinoma.

For more information please contact the clinical research department: 631-675-5075